Le Lézard
Classified in: Health, Science and technology
Subjects: CALENDAR OF EVENTS, HEALTH

Minovia Therapeutics to Present at Biotech Showcase on Tuesday, January 10, 2023


WOBURN, Mass. and HAIFA, Israel, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minovia Therapeutics, a clinical-stage global biotechnology company, today announced that the Company will be presenting at the Biotech Showcase on Tuesday, January 10, 2023, at the Hilton San Francisco Union Square Hotel in San Francisco, CA.

Time: 9:45 AM PST

Track: Franciscan C (Ballroom Level)

Biotech Showcase is an investor conference featuring insights from top investors and biopharma executives.

Interested parties can register to attend the event here:

https://informaconnect.com/biotech-showcase/registration-options/

Additionally, CEO Natalie Yivgi-Ohana and CBO Shai Melcer will be in San Francisco from January 8-12, 2023, during the 41st Annual J.P. Morgan Health Care Conference and will be available for meetings with investors.

Individuals interested in meeting with CEO Natalie Yivgi-Ohana and CBO Shai Melcer can contact shai.melcer@minoviatx.com

About Minovia
Minovia Therapeutics is a clinical-stage global biotechnology company committed to the discovery and development of novel approaches to treating diseases caused by mitochondrial dysfunction. Minovia's Mitochondrial Augmentation Technology (MAT) platform is designed to extend and enhance human lives by restoring mitochondrial function using autologous stem cells enriched with healthy, functional mitochondria. This unique approach capitalizes on the natural ability of mitochondria to transfer between cells. The company's initial clinical focus is on primary mitochondrial diseases, such as Pearson syndrome, a fatal pediatric disease, and hematological disorders that include mitochondrial dysfunction.

Findings on safety and efficacy of MAT, both pre-clinical and clinical, may be found in these publications:

https://www.nature.com/articles/s41536-021-00167-7

https://www.science.org/doi/10.1126/scitranslmed.abo3724

Minovia was founded by leading researchers in mitochondrial biology and is headquartered in Haifa, Israel, with operations in Massachusetts.

For more information, visit http://minoviatx.com/.

Contact Information

Shai Melcer, CBO

3 HaSadna st., Tirat Carmel

Israel

Shai.melcer@minoviatx.com

+972-747033354



These press releases may also interest you

at 11:18
SHINE Technologies Appoints Experienced Company Builder to Board of Directors
SHINE Technologies, LLC, a next-generation fusion technology company, today announced the appointment of Dr. Frederick Robertson to the company's board of directors....

at 11:17
GlobalMed®, a Partner with Valor Healthcare, Awarded Contract to Provide Remote Patient Monitoring to the VA Office of Connected Care
GlobalMed, the leading provider of virtual health solutions to the Department of Veterans Affairs (VA), is a leading partner on the Valor Healthcare Team awarded to deliver Remote Patient Monitoring (RPM) services to the VA's Office of Connected...

at 11:12
AARP NY Applauds State Lawmakers for Passing Rx Price Transparency Bill; Urges Governor to Sign
AARP New York State Director Beth Finkel issued the following statement after both the State Assembly and State Senate passed a bill to require drug makers to report planned price increases of at least 16% over two years:...

at 11:07
NIH STUDY LINKS PRENATAL PER- AND POLYFLUOROALKYL SUBSTANCE EXPOSURE TO HIGHER BMI & OBESITY RISK IN CHILDREN
Exposure to per- and polyfluoroalkyl substances (PFAS) during pregnancy was linked to slightly higher BMIs and an increased risk of obesity in children, according to new research funded by the Environmental influences on Child Health Outcomes...

at 11:04
New Equality Health at Home Helps Complex Patients Navigate Healthcare System, Address SDoH and Reconnect to Primary Care Provider
Equality Health at Home is the latest addition in the comprehensive Equality Health Network offering and the company's leading value-based care model dedicated to serving independent primary care practices (PCPs) and their patients to close gaps in...

at 11:00
Lyric (formerly ClaimsXten Portfolio) to Add Genetic Testing Edits Module to its Market Leading Payment Accuracy Solutions
In late April, ClaimsXten Portfolio--a market leader in claim editing solutions--became Lyric, with a vision to simplify the business of care. The strategic partnership announced today combines Lyric's market-leading claims editing solution with...

More news about Health...


News published on and distributed by: